Theodore Samuelsto - Perrigo Company Independent Director

PRGO -- USA Stock  

USD 55.72  0.98  1.73%

  Director
Mr. Theodore R. Samuelsto was appointed as an Independent Director of the Company, effective January 4, 2017. Mr. Samuels has served as President of Capital Guardian Trust Company, a Capital Group company, since 2010 and an equity portfolio manager and investment analyst at Capital Group since 1981. Capital Group is one of the most prominent investors inthe United Statesand globally, delivering longterm results for investors using highconviction portfolios, rigorous research, and individual accountability
  Director Since 2017  MBA    
353 1 709 4000  http://www.perrigo.com
Samuels has evaluated numerous companies across all sectors and has served on many management and investment committees, with an eye toward shareholder value creation. He holds a B.A. from Harvard College and an MBA from Harvard Business School.

Management Efficiency

The company has return on total asset (ROA) of 2.34 % which means that it generated profit of $2.34 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 1.49 % meaning that it created $1.49 on every $100 dollars invested by stockholders.
The company currently holds 3.62B in liabilities with Debt to Equity (D/E) ratio of 63.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Perrigo Company has Current Ratio of 1.88 which is within standard range for the sector.

Similar Executives

Showing few of many executives

DIRECTOR Since

Michael TrimbleOrigin Agritech Limited
2006
David BullockOrigin Agritech Limited
2015
Geoffery MerszeiOrigin Agritech Limited
2016
Robert ScullyZoetis
2013
Marc TessierLavigneRegeneron Pharmaceuticals
2011
Terrence KearneyVertex Pharmaceuticals Incorpor
2011
James KangOrigin Agritech Limited
2010
Kalpana MorpariaDr Reddys Laboratories Ltd
2007
Hans HaslerDr Reddys Laboratories Ltd
2016
Alan GarberVertex Pharmaceuticals Incorpor
2017
William YoungVertex Pharmaceuticals Incorpor
2014
William SteereZoetis
2013
Bruce SachsVertex Pharmaceuticals Incorpor
2017
Paul BisaroZoetis
2015
Prasad MenonDr Reddys Laboratories Ltd
2019
Omkar GoswamiDr Reddys Laboratories Ltd
2000
Sanjay KhoslaZoetis
2013
Margaret McGlynnVertex Pharmaceuticals Incorpor
2011
Michael BrownRegeneron Pharmaceuticals
1991
Yuchun LeeVertex Pharmaceuticals Incorpor
2012
J MoreauDr Reddys Laboratories Ltd
2007

Entity Summary

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people.Perrigo Company plc (PRGO) is traded on BATS Exchange in USA and employs 10,600 people.

Perrigo Company Leadership Team

John Hendrickson, President
Gary Cohen, Independent Director
Arthur Shannon, IR Contact Officer
Ronald Winowiecki, Acting CFO
Svend Andersen, Executive Vice President and President - Consumer Healthcare International
Judy Brown, CFO and Executive VP
Laurie Brlas, Independent Director
Donal OConnor, Independent Director
James Michaud, Chief Human Resource Officer, Executive Vice President
Louis Yu, Executive Vice President - Global Quality
John Wesolowski, Executive Vice President and Presidentident - RX
Theodore Samuelsto, Independent Director
Scott Jamison, Executive Vice President General Manager - Nutritionals
Ellen Hoffing, Independent Director
Marc Coucke, Executive Vice President General Manager - Omega Pharma Business
Adriana Karaboutis, Independent Director
Michael Jandernoa, Independent Director
Paul Weninger, Executive Vice President - Global Quality Operations
Thomas Farrington, Senior Vice President CIO
Herman Morris, Independent Director
Jeffrey Needham, Executive Vice President General Manager - Consumer Healthcare
Todd Kingma, Executive VP, General Counsel and Secretary
Rolf Classon, Independent Director
Raymond Silcock, CFO
Shlomo Yanai, Independent Director Nominee
Jatin Shah, Senior Vice President Chief Scientific Officer
Michael Stewart, Senior Vice President - Global Human Resources
Jeffrey Kindler, Independent Director
Jacqualyn Fouse, Independent Director
Grainne Quinn, Executive Vice President Chief Medical Officer
Theodore Samuels, Independent Director
Geoffrey Parker, Independent Director
Murray Kessler, President CEO, Director
Sharon Kochan, Executive VP and General Manager of International
Gary Kunkle, Lead Independent Director
Joseph Papa, Chairman and CEO
Marry Brlas, Independent Chairman of the Board
Bradley Alford, Independent Director
Jeffrey Smith, Independent Director
Bradley Joseph, IR Contact Officer
James Dillard, Executive Vice President Chief Scientific Officer
Douglas Boothe, Executive Vice President General Manager - Rx Pharmaceuticals
Ronald Janish, Executive Vice President - Global Operations and Supply Chain
Uwe Rohrhoff, President CEO, Director

Stock Performance Indicators

Did you try this?

Run Positions Ratings Now

   

Positions Ratings

Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Currently Active Assets on Macroaxis

HCP   
Purchased over 300 shares of
few hours ago
Traded for 35.11
PAGS   
Sold over 200 shares of
few hours ago
Traded for 47.76
AVP   
Purchased over 100 shares of
few hours ago
Traded for 4.78
MOH   
Purchased over 100 shares of
few hours ago
Traded for 115.25
TTD   
Purchased over 50 shares of
few hours ago
Traded for 213.25
Additionally take a look at Your Equity Center. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.
Search macroaxis.com